Heads up: some links below are affiliate links — assume any provider we list may compensate us, at no cost to you. It never buys a better score, but the providers we work with are listed first. See our affiliate disclosure.
Alternatives · ranked for speed
LillyDirect Foundayo lands at #121 on our ranking with a Rx-Readiness Score of 61/100. If it isn't the right fit, here are the strongest alternatives on our shortlist — scored on the same readiness rubric of speed to first dose, flat pricing, no-video signup, access, molecule choice and a clean off-ramp.
Top alternative
The async, needle-optional value play: oral or injectable semaglutide and tirzepatide from a low starting price, no video visit, ~3 days to a script — listed with its February 2026 FDA warning letter in plain view.
Ranked #62 · Grade C
From $133/mo semaglutide, $209/mo tirzepatide, all 50 states, and an explicit pregnancy/breastfeeding exclusion most competitors don't bother disclosing — the price just isn't flat, it's tiered by how many months you prepay.
Ranked #35 · Grade C
The async standout: no video visit, no quiz wall, prices posted in the open, and needle-free tablets alongside the injections — but the headline price is a starting dose, not a flat rate, and only 36 states are in.
Ranked #117 · Grade C
A sublingual (under-the-tongue), not injectable, GLP-1 program — $189/mo semaglutide and $319/mo tirzepatide on a 6-month prepay plan, $209/mo and $359/mo on a shorter 2-month plan — serving 34 states plus DC.
Ranked #150 · Grade C
Names four specific 503A compounding pharmacy partners directly — from $150/mo semaglutide, $241/mo tirzepatide on a 6-month plan, available as injection, drops, or pills — though state coverage isn't published.
Ranked #49 · Grade C
The posted price is half the bill, and the site says so itself. Read live on 26 August 2026, the weight-loss catalog is ten FDA-approved brand listings — Wegovy as a pill and a pen, Zepbound as a vial and a KwikPen, Ozempic in both forms, Mounjaro, and two new oral tablets in the Ozempic Pill and Foundayo — and every single one carries the same footnote: the figure covers medication only, and a membership at $39 for the first month then $149 a month is required and billed separately. So the $149 Wegovy Pill is really about $298 a month and the $299 Zepbound vial is about $448. That membership is not nothing — 24/7 messaging with licensed providers, monthly care-team follow-ups, a smart scale and named in-house clinicians — but it is $1,788 a year on top of the drug. One oddity to open before you buy: Mounjaro and one of two Zepbound listings are posted at a flat $1,899 a month on the same page as Zepbound vials at $299, and nothing explains the gap. Its FAQ asks whether video visits are required and whether all states are served, but keeps both answers inside collapsed panels, so neither could be verified. It carries two FDA warning letters dated 9 September 2025 over the compounded-semaglutide business it has since left behind entirely.
Ranked #133 · Grade C
A microdose-or-full-strength compounded shop — starting at $149/mo semaglutide, $249/mo tirzepatide — with a 4.9-star Google rating and a stated 15,000+ clients served, though the compounding pharmacy itself isn't named on the site.
Ranked #96 · Grade C
A 3-month starter-bundle model — $99/mo semaglutide, $133/mo tirzepatide, medication plus shipping, consult and an injection kit included — serving all 50 states with no membership fees.
Ranked #144 · Grade C
A major, highly recognizable brand — Amazon's own One Medical plus Amazon Pharmacy channel — offering FDA-approved Wegovy from $149/mo with a manufacturer coupon, plus the new oral Foundayo pill, though the $149 price depends on coupon eligibility.
Ranked #164 · Grade C
An established longevity-telehealth brand with a microdose-first GLP-1 menu — starting at $99/mo microdosing semaglutide, $159/mo microdosing tirzepatide — plus brand-name Wegovy/Zepbound access-and-monitoring for a separate $50–$65 fee (drug cost billed apart).
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Scores are our editorial judgment per the methodology. Not medical advice; see our disclosure.